Recruiting
Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer
NCT04215731
- Conditions
- Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
- Locations
-
- The Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China